Condition
Stage III Periodontitis
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (2)
Trial Status
Recruiting2
Active Not Recruiting1
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07368699Not ApplicableRecruitingPrimary
Active Oxygen Releasing Gel With Photodynamic Therapy in Treating Stage III Periodontitis
NCT07551297Not ApplicableCompleted
Ozone Therapy After Open Flap Debridement in Periodontitis
NCT07438977Not ApplicableActive Not RecruitingPrimary
Evaluation of Serum TRACP-5b, BALP, and 25-Hydroxyvitamin D3 Levels in Stage III Periodontitis Patients
NCT07316023Phase 2RecruitingPrimary
Antimicrobial Photodynamic Therapy With ICG-Loaded Nanoparticles for Periodontitis Management
NCT06675578Phase 2Not Yet Recruiting
Treatment of Periodontitis by Tulsi Gel
Showing all 5 trials